The Beatrice Hunter Cancer Research Institute logo
  • Investigator Awards

BHCRI Funding Opportunities

Seed Funds and Miscellaneous Funds are designed for rapid turnaround and have no set due date. Applications are reviewed by the BHCRI Research Committee at regularly scheduled committee meetings. Applications will need to be submitted to the BHCRI office at least two weeks before a committee meeting. Please see Research Committee meeting schedule: https://bhcri.ca/committee-meetings

A completed Funding Overlap Declaration is to be submitted with all applications. 

Funding for Seed and Miscellaneous grants is provided by the Dalhousie Medical Research Foundation (DMRF) and the New Brunswick Health Research Foundation (NBHRF) as outlined below.

DMRF can support researchers at Dalhousie University and affiliated health centres (including Dalhousie Medicine New Brunswick). NBHRF funds are to support researchers based at institutions in New Brunswick.  BHCRI serves as the peer review mechanism for New Brunswick-based researchers.  Recommendations for New Brunswick applicants will be forwarded to NBHRF and final funding decisions will be determined by NBHRF.

Eligible Principal Investigators include Dalhousie (including Dalhousie Medicine New Brunswick) or New Brunswick-based BHCRI Senior Scientists, Scientists, Associate Members or Honorary Members (qualifying as Senior Scientists, Scientists or Associate Members at Dalhousie) in good standing and whose project is clearly focused on cancer.
Seed Funds guidelines and application. 

• Miscellaneous Funds guidelines and application

 

The Early Career Awards will be offered once per year with a set deadline. A Scientific Review Committee will be appointed to review the grant submissions. Applicants must be within the first seven years of their initial academic appointment and be a member of BHCRI and eligible to hold grant funds. The Early Career Awards will be for $50,000 per year for two years. As many as three grants per year will be offered with one each to basic, clinical and population researchers, with this last category very broadly defined.

The 2022 Beatrice Hunter Cancer Research Institute Early Career Awards competition is now open.

Funding for 2022 Early Career competition is provided by the Dalhousie Medical Research Foundation (DMRF) and the New Brunswick Health Research Foundation (NBHRF) as outlined below.

DMRF funds are to support researchers based at Dalhousie University (including Dalhousie Medicine New Brunswick). NBHRF funds are to support researchers based at institutions in New Brunswick. Therefore, for this 2022 competition, only faculty members at Dalhousie or a New Brunswick-based institution are eligible to apply. BHCRI serves as the peer review mechanism for New Brunswick-based researchers. SRC recommendations will be forwarded to NBHRF and final funding decisions will be determined by NBHRF under their Establishment Grant program.


The deadline for Letter of Intent submission is 4:00pm ADT on 10 September, 2021. Full applications are due October 15, 2021, upon approval of LOI’s.
 

Please view the Early Career application and review criteria

 

Congratulations to the recipients of 2020 BHCRI/DMRF New Investigator Awards

Congratulations to the recipients of 2018 BHCRI New Investigator Awards

Congratulations to the recipients of 2017 BHCRI New Investigator Awards and Ivor Hamilton Cancer Care & Education Awards

Congratulations to the recipients of 2017 Breast Cancer Society of Canada/QEII Foundation Awards

Congratulations to the recipients of 2016 New Investigator Awards

Congratulations to the recipients of 2016 Breast Cancer Society of Canada/QEII Foundation Awards

Congratulations to the recipients of 2015 New Investigator Awards

Congratulations to the recipients of 2015 Breast Cancer Society of Canada/QEII Foundation Awards

 

Site by: Spectacle Group